Literature DB >> 17992496

[Medical therapy of complications in liver cirrhosis].

F Grünhage1, J Heller, B Appenrodt, V Schmitz, T Sauerbruch.   

Abstract

Patients with liver cirrhosis bear a considerable risk of a variety of complications that involve virtually all organ systems. They can be addressed with a wide spectrum of drugs for acute interventions as well as for prophylactic purposes. At the same time treatment of the underlying disease, the identification and treatment of triggering factors and the possibility of liver transplantation should be kept in mind.

Entities:  

Mesh:

Year:  2007        PMID: 17992496     DOI: 10.1007/s00108-007-1965-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  31 in total

Review 1.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

2.  A practice guideline on Wilson disease.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

3.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

Review 4.  Management of acute bleeding from portal hypertension.

Authors:  Dominique Thabut; Brigitte Bernard-Chabert
Journal:  Best Pract Res Clin Gastroenterol       Date:  2007       Impact factor: 3.043

5.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

6.  Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study.

Authors:  J Vorobioff; R J Groszmann; E Picabea; M Gamen; R Villavicencio; J Bordato; I Morel; M Audano; H Tanno; E Lerner; M Passamonti
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

7.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

8.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

9.  Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study.

Authors:  K A Brensing; J Textor; J Perz; P Schiedermaier; P Raab; H Strunk; H U Klehr; H J Kramer; U Spengler; H Schild; T Sauerbruch
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

10.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.